<?xml version="1.0" encoding="UTF-8"?>
<ref id="dkx118-B29">
 <label>29</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Canducci</surname>
    <given-names>F</given-names>
   </name>,
   <name name-style="western">
    <surname>Ceresola</surname>
    <given-names>ER</given-names>
   </name>, 
   <name name-style="western">
    <surname>Boeri</surname>
    <given-names>E</given-names>
   </name>
  </person-group>
  <etal/>
  <article-title>Cross-resistance profile of the novel integrase inhibitor dolutegravir (S/GSK1349572) using clonal viral variants selected in patients failing raltegravir</article-title>.
  <source>J Infect Dis</source>
  <year>2011</year>; 
  <volume>204</volume>:
  <fpage>1811</fpage>â€“
  <lpage>5</lpage>.
  <pub-id pub-id-type="pmid">21984737</pub-id>
 </mixed-citation>
</ref>
